Neurocognitive outcome in patients with hypertyrosinemia type I after long-term treatment with NTBC
Neurocognitive outcome in patients with hypertyrosinemia type I after long-term treatment with NTBC
About this item
Full title
Author / Creator
Publisher
Dordrecht: Springer Netherlands
Journal title
Language
English
Formats
Publication information
Publisher
Dordrecht: Springer Netherlands
Subjects
More information
Scope and Contents
Contents
Objective
The implementation of NTBC into treatment of hypertyrosinemia type I (HT I) greatly improved survival by prevention of acute liver failure and hepatocellular carcinoma. However, there are first reports of cognitive impairment in patients with elevated plasma tyrosine concentrations.
Methods
We here assess the neurocognitive devel...
Alternative Titles
Full title
Neurocognitive outcome in patients with hypertyrosinemia type I after long-term treatment with NTBC
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1221143854
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1221143854
Other Identifiers
ISSN
0141-8955
E-ISSN
1573-2665
DOI
10.1007/s10545-011-9394-5
